Sign in

CIK 0000725363

  • Non-accelerated filer
  • Smaller reporting company

CEL SCI CORP

Sign in to watch
Ticker
CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
CO
Entity type
Operating
EIN
840916344
Phone
+1 703-506-9460
Business address
8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
  1. 4 Grant or award Chief Executive Officer acquired 483 shares (grant or award)
  2. 4 Open-market buy Chief Executive Officer bought 3,725 shares at $6.71 ($24,995)
  3. 4 Grant or award Senior Vice President acquired 382 shares (grant or award)
  4. 4 Grant or award Chief Scientific Officer acquired 268 shares (grant or award)
  5. 4 Grant or award Senior Vice President acquired 410 shares (grant or award)
  6. 4 Grant or award Chief Executive Officer acquired 461 shares (grant or award)
  7. 4 Open-market sale Senior Vice President sold 8,000 shares at $8.69 ($69,559)
  8. 4 Grant or award Senior Vice President acquired 2,375 shares (grant or award)
  9. 4 Grant or award Senior Vice President acquired 2,095 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 3,492 shares (grant or award)
  11. 4 Open-market sale Senior Vice President sold 8,000 shares at $7.03 ($56,208)
  12. 4 Grant or award Chief Executive Officer acquired 6,631 shares (grant or award)
  13. 4 Open-market buy Director bought 2,000 shares at $5.00 ($10,000)
  14. 4 Grant or award Director acquired 1,458 shares (grant or award)
  15. 4 Grant or award Senior Vice President acquired 4,373 shares (grant or award)
  16. 4 Grant or award Senior Vice President acquired 2,915 shares (grant or award)
  17. 4 Grant or award Senior Vice President acquired 7,289 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 14,577 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 41 · 806 filings